Get the Stockscreener App
13.01
7.01%
-0.98
After Hours:
12.80
-0.21
-1.61%
Neuphoria Therapeutics Inc stock is traded at $13.01, with a volume of 63,853.
It is down -7.01% in the last 24 hours and up +76.78% over the past month.
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.
See More
Previous Close:
$13.99
Open:
$14
24h Volume:
63,853
Relative Volume:
1.41
Market Cap:
$24.46M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+9.42%
1M Performance:
+76.78%
6M Performance:
+162.83%
1Y Performance:
+0.00%
1-Day Range:
$12.74
$14.00
1-Week Range:
$11.36
$15.14
52-Week Range:
$2.90
$15.14
Neuphoria Therapeutics Inc Stock (NEUP) Company Profile
Name
Neuphoria Therapeutics Inc
Sector
Industry
Phone
781-439-5551
Address
100 SUMMIT DR, BURLINGTON
Compare NEUP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NEUP
Neuphoria Therapeutics Inc
|
13.01 | 26.17M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-28-23 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Sep-28-23 | Reiterated | Maxim Group | Buy |
| Jan-10-22 | Initiated | Berenberg | Buy |
| Jan-10-22 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-10-22 | Initiated | Evercore ISI | Outperform |
| Jan-10-22 | Initiated | H.C. Wainwright | Buy |
View All
Neuphoria Therapeutics Inc Stock (NEUP) Latest News
Real time alert setup for Neuphoria Therapeutics Inc. performanceJuly 2025 PreEarnings & Capital Efficient Trade Techniques - newser.com
When is the best time to exit Neuphoria Therapeutics Inc.July 2025 Sector Moves & Fast Gain Stock Tips - Newser
Neuphoria Therapeutics Inc. recovery potential after sell off2025 Trade Ideas & Weekly Momentum Picks - Newser
Building trade automation scripts for Neuphoria Therapeutics Inc.July 2025 Outlook & Free Safe Capital Growth Stock Tips - Newser
How hedge fund analytics apply to Neuphoria Therapeutics Inc. stockJuly 2025 Reactions & High Accuracy Investment Signals - Newser
Published on: 2025-09-12 13:50:26 - Newser
Will Neuphoria Therapeutics Inc. benefit from macro trendsChart Signals & High Accuracy Swing Trade Signals - Newser
Using portfolio simulators with Neuphoria Therapeutics Inc. includedJuly 2025 Institutional & Safe Capital Investment Plans - Newser
Can a trend reversal in Neuphoria Therapeutics Inc. lead to recoveryTrade Volume Report & Real-Time Sentiment Analysis - Newser
Can trapped investors hope for a rebound in Neuphoria Therapeutics Inc.Earnings Growth Summary & Real-Time Chart Breakout Alerts - Newser
Custom watchlist performance reports with Neuphoria Therapeutics Inc.July 2025 WrapUp & AI Powered Buy/Sell Recommendations - Newser
Is it time to cut losses on Neuphoria Therapeutics Inc.2025 Performance Recap & Stepwise Trade Execution Plans - Newser
Using RSI to spot recovery in Neuphoria Therapeutics Inc.Trade Entry Summary & Daily Growth Stock Investment Tips - Newser
Sentiment analysis tools applied to Neuphoria Therapeutics Inc.Share Buyback & Verified Trade Idea Suggestions - Newser
What data driven models say about Neuphoria Therapeutics Inc.’s futureMarket Performance Report & Daily Risk Controlled Trade Plans - Newser
Developing predictive dashboards with Neuphoria Therapeutics Inc. dataJuly 2025 Recap & Fast Entry Momentum Alerts - Newser
How high can Neuphoria Therapeutics Inc. stock go2025 Stock Rankings & Weekly High Return Stock Opportunities - Newser
Using flow based indicators on Neuphoria Therapeutics Inc.Weekly Earnings Recap & Real-Time Volume Trigger Notifications - Newser
Published on: 2025-09-10 02:06:53 - Newser
What to expect from Neuphoria Therapeutics Inc. in the next 30 days2025 Technical Overview & Stepwise Trade Execution Plans - Newser
Exit strategy if you’re trapped in Neuphoria Therapeutics Inc.Treasury Yields & AI Powered Trade Plan Recommendations - Newser
How to build a dashboard for Neuphoria Therapeutics Inc. stock2025 Market WrapUp & Long-Term Capital Growth Strategies - Newser
Chart based analysis of Neuphoria Therapeutics Inc. trendsJuly 2025 Highlights & Real-Time Volume Analysis - Newser
Will Neuphoria Therapeutics Inc. outperform the marketQuarterly Portfolio Review & Reliable Entry Point Alerts - Newser
Is Neuphoria Therapeutics Inc. a good ESG investmentBond Market & Short-Term High Return Strategies - Lancaster City Council
Neuphoria Therapeutics Inc. stock trend forecastTrade Analysis Summary & Safe Entry Trade Reports - Newser
Can Neuphoria Therapeutics Inc. recover in the next quarterWeekly Gains Summary & Daily Stock Trend Watchlist - Newser
How to integrate Neuphoria Therapeutics Inc. into portfolio analysis toolsFed Meeting & Smart Money Movement Alerts - Newser
How to forecast Neuphoria Therapeutics Inc. trends using time seriesEarnings Risk Summary & Real-Time Chart Breakout Alerts - Newser
Neuphoria Therapeutics Inc Stock (NEUP) Financials Data
There is no financial data for Neuphoria Therapeutics Inc (NEUP). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):